×
About 30,710 results

ALLMedicine™ Mechanical Ventilation Center

Research & Reviews  10,104 results

WHO advises against use of convalescent plasma for covid-19
https://www.bmj.com/company/newsroom/who-advises-against-use-of-convalescent-plasma-for-covid-19/
BMJ

Dec 6th, 2021 - Current evidence shows no improvement in survival and other important measures Convalescent plasma (a transfusion of blood plasma from someone who has recovered from covid-19) is not recommended for patients with covid-19, says a WHO Guideline ...

Relationship between nutrition therapy in the acute phase and outcomes of ventilated pa...
https://doi.org/10.1093/ajcn/nqac014
The American Journal of Clinical Nutrition; Nakamura K, Hatakeyama J et. al.

Jan 20th, 2022 - Optimal nutrition therapy has not yet been established for the acute phase of severe coronavirus disease 2019 (COVID-19) infection. To examine the effects of nutrition delivery in the acute phase on the mortality and long-term outcomes of post-int...

Novel investigational treatments for ventilator-associated pneumonia and critically ill...
https://doi.org/10.1080/13543784.2022.2030312
Expert Opinion on Investigational Drugs; Cusack R, Garduno A et. al.

Jan 19th, 2022 - Ventilator-associated pneumonia (VAP) is common; its prevalence has been highlighted by the Covid-19 pandemic. Even young patients can suffer severe nosocomial infection and prolonged mechanical ventilation. Multidrug-resistant bacteria can spread...

End-tidal Carbon Dioxide for Diagnosing Anaphylaxis in Patients with Severe Postinducti...
https://doi.org/10.1097/ALN.0000000000004123
Anesthesiology Erlich C, Lamer A et. al.

Jan 19th, 2022 - Perioperative hypersensitivity reactions may be difficult to diagnose during general anesthesia. Postinduction hypotension is the most common sign but is not specific. It was recently suggested that low end-tidal carbon dioxide (ETco2) might be a ...

see more →

Guidelines  22 results

WHO advises against use of convalescent plasma for covid-19
https://www.bmj.com/company/newsroom/who-advises-against-use-of-convalescent-plasma-for-covid-19/
BMJ

Dec 6th, 2021 - Current evidence shows no improvement in survival and other important measures Convalescent plasma (a transfusion of blood plasma from someone who has recovered from covid-19) is not recommended for patients with covid-19, says a WHO Guideline ...

Management of maternal COVID-19: considerations for anesthesiologists.
https://doi.org/10.1097/ACO.0000000000001001
Current Opinion in Anaesthesiology; Bernstein K, Landau R

Apr 20th, 2021 - To describe updates to pragmatic recommendations that were published during the first coronavirus disease 2019 (COVID-19) surge, including the current thinking about whether pregnancy worsens the severity of COVID-19. Although a majority of pregna...

Prolonged Weaning: S2k Guideline Published by the German Respiratory Society.
https://doi.org/10.1159/000510085
Respiration; International Review of Thoracic Diseases; Schönhofer B, Geiseler J et. al.

Dec 11th, 2020 - Mechanical ventilation (MV) is an essential part of modern intensive care medicine. MV is performed in patients with severe respiratory failure caused by respiratory muscle insufficiency and/or lung parenchymal disease; that is, when other treatme...

Long-Term Mechanical Ventilation: Recommendations of the Swiss Society of Pulmonology.
https://doi.org/10.1159/000510086
Respiration; International Review of Thoracic Diseases; Janssens JP, Michel F et. al.

Dec 11th, 2020 - Long-term mechanical ventilation is a well-established treatment for chronic hypercapnic respiratory failure (CHRF). It is aimed at improving CHRF-related symptoms, health-related quality of life, survival, and decreasing hospital admissions. In S...

A living WHO guideline on drugs for covid-19.
https://doi.org/10.1136/bmj.m3379
BMJ (Clinical Research Ed.); Agarwal A, Rochwerg B et. al.

Sep 6th, 2020 - This is the eighth version (seventh update) of a living guideline. It replaces earlier versions (4 September 2020, 20 November 2020, 17 December 2020, 31 March 2021, 6 July 2021, 23 September 2021, and 6 December 2021). The previous versions can b...

see more →

Drugs  134 results see all →

Clinicaltrials.gov  995 results

WHO advises against use of convalescent plasma for covid-19
https://www.bmj.com/company/newsroom/who-advises-against-use-of-convalescent-plasma-for-covid-19/
BMJ

Dec 6th, 2021 - Current evidence shows no improvement in survival and other important measures Convalescent plasma (a transfusion of blood plasma from someone who has recovered from covid-19) is not recommended for patients with covid-19, says a WHO Guideline ...

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)
https://clinicaltrials.gov/ct2/show/NCT05085574

Jan 14th, 2022 - Participants will be randomly assigned, in a 1:1 ratio, to one of two regimens, with 202 subjects per group as follows: Group 1 (study product) subjects will receive 80 mg famotidine by mouth (PO) 4 times per day (QID) + 400 mg celecoxib as a firs...

Surfactant Nebulization for the Early Aeration of the Preterm Lung
https://clinicaltrials.gov/ct2/show/NCT04315636

Jan 13th, 2022 - Respiratory distress syndrome is the most common cause of respiratory failure in preterm infants. Treatment consists of respiratory support and exogenous surfactant administration. Commonly, surfactant is administered via an endotracheal tube duri...

Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death
https://clinicaltrials.gov/ct2/show/NCT04284319

Jan 13th, 2022 - The current procedure of DCD organ donation and procurement follows a well-established course for lung, liver, kidney and pancreas transplantation in the United States. After consent has been obtained, the organs are allocated through UNOS. When a...

A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19
https://clinicaltrials.gov/ct2/show/NCT05164133

Jan 13th, 2022 - This is a single-arm, open-label study to assess the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of tocilizumab (TCZ) for the treatment of pediatric patients from birth to less than 18 years old hospitalized with COVID-19 ...

see more →

News  1,023 results

WHO advises against use of convalescent plasma for covid-19
https://www.bmj.com/company/newsroom/who-advises-against-use-of-convalescent-plasma-for-covid-19/
BMJ

Dec 6th, 2021 - Current evidence shows no improvement in survival and other important measures Convalescent plasma (a transfusion of blood plasma from someone who has recovered from covid-19) is not recommended for patients with covid-19, says a WHO Guideline ...

Are Hospital Admissions Still the Best Way to Gauge the COVID Crisis?
https://www.medscape.com/viewarticle/966821

Jan 20th, 2022 - MADRID/LONDON (Reuters) - Using the number of people in hospital with COVID-19 to gauge the severity of the pandemic may not give an accurate picture in the Omicron era as more and more patients with the virus are being admitted for other reasons,...

COVID Behind Bars or on the Streets Linked to Hospitalization
https://www.medpagetoday.com/infectiousdisease/covid19/96662

Jan 13th, 2022 - Incarcerated and homeless individuals presenting to the emergency department required more and longer hospital care for COVID-19 than other infected patients, researchers found in a cross-sectional study. Comparing emergency department and hospita...

Hyperbaric Oxygen Resolves COVID-19 Breathing Problems Much Faster Than Standard Therapy
https://www.medscape.com/viewarticle/966232

Jan 10th, 2022 - NEW YORK (Reuters Health) - Hyperbaric oxygen (HBO2) appears to resolves severe COVID-19 breathing problems in a median of three days compared with nine days with standard therapy, researchers in Argentina report. "Our findings support the safety ...

CDC: Pfizer Vaccine Blunts Severe COVID Complication in Teens
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/96572

Jan 7th, 2022 - Two doses of Pfizer/BioNTech vaccine bolstered protection against multi-system inflammatory syndrome (MIS-C) in adolescents ages 12 to 18, researchers found. The vaccine was 91% (95% CI 78%-97%) effective in protecting fully vaccinated adolescents...

see more →

Patient Education  6 results see all →